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ABSTRACT
To get insight in the endocrine and metabolic responses in children
with meningococcal sepsis 26 children were studied the first 48 h after
admission. On admission there was a significant difference in cortisol/
ACTH levels between nonsurvivors (n 5 8) and survivors (n 5 18).
Nonsurvivors showed an inadequate cortisol stress response in com-
bination to very high ACTH levels, whereas survivors showed a nor-
mal stress response with significantly higher cortisol levels (0.62 vs.
0.89 mmol/L) in combination with moderately increased ACTH levels
(1234 vs. 231 ng/L). Furthermore, there was a significant difference
between nonsurvivors and survivors regarding pediatric risk of mor-
tality score (31 vs. 17), TSH (0.97 vs. 0.29 mE/L), T3 (0.53 vs. 0.38
nmol/L), reverse T3 (rT3) (0.75 vs. 1.44 nmol/L), C-reactive protein (34
vs. 78 mg/L), nonesterified fatty acids (0.32 vs. 0.95 mmol/L), and
lactate (7.3 vs. 3.2 mmol/L). In those who survived, the most impor-
tant changes within 48 h were seen in a normalization of cortisol and
ACTH levels, but without a circadian rhythm; a decrease of rT3 and
an increase in the T3/rT3 ratio; and a decrease in the levels of the
nonesterified free fatty acids and an unaltered high urinary nitrogen
excretion. At this moment, it is yet unknown whether the hormonal
abnormalities are determining factors in the outcome of acute me-
ningococcal sepsis or merely represent secondary effects. Under-
standing the metabolic and endocrine alterations is required to design
possible therapeutic approaches. The striking difference between
nonsurvivors and survivors calls for reconsideration of corticosteroid
treatment in children with meningococcal sepsis. (J Clin Endocrinol
Metab 85: 3746–3753, 2000)
SEPTIC SHOCK WITH purpura is a life-threatening clin-ical syndrome predominantly caused by Neisseria men-
ingitidis and characterized by a sudden onset and rapid pro-
gression of disease. The physiological changes that constitute
the process of sepsis are induced by microbial agents during
bloodstream infection or by the toxic products of pathogens
that are released from sites of focal infection. This process
involves changes generated by the immune system in which
hormones, cytokines, and enzymes are involved.
In adult patients it has been shown that sepsis may lead
to pronounced neuro-endocrine and metabolic alterations
including increased serum cortisol concentrations; low thy-
roid hormones; insulin resistance; elevations of plasma glu-
cose, lactate, and free fatty acid concentrations; and increased
muscle protein breakdown (1–4). During the time course of
sepsis an ebb and flow phase can be detected. Main features
in the ebb phase are a decrease in metabolic rate and tem-
perature, and in the flow phase there is an increase in met-
abolic rate and urinary nitrogen excretion (5, 6). There are
several differences between the host response of young chil-
dren compared with adults during meningococcal sepsis (7).
Little is known about the neuro-endocrine changes in criti-
cally ill infants and children. Previous studies in critically ill
infants and children showed an altered thyroid function at
the onset of acute diseases called “the euthyroid sick syn-
drome” (8–12). Dopamine infusion induces or aggravates
partial hypopituitarism in newborn infants, resulting in in-
hibited PRL and GH secretion (8). The present study was
undertaken to evaluate the time course of the endocrine and
metabolic responses of children with meningococcal sepsis
during the first 48 h of admission in the pediatric intensive
care unit (PICU).
Materials and Methods
Study protocol
Children above 3 months and below 18 yr of age with septic shock
and petechiae/purpura requiring intensive care treatment were enrolled
in this study. The group consisted of children primary admitted or
referred to the PICU of the Sophia Children’s Hospital between October
1997 and October 1998. Patients were eligible for inclusion when they
met the following criteria: 1) presence of petechia/purpura; and 2)
presence of shock for less than 6 h, defined as persistent hypotension
(systolic blood pressure ,75 mm Hg for children between 3 and 12
months, ,80 mm Hg for 1–5 yr, ,85 mm Hg for 6–12 yr, ,100 mm Hg
for children older than 12 yr), or evidence of poor end-organ perfusion,
defined as at least two of the following: unexplained metabolic acidosis
(pH ,7.3 or base excess less than 25 mmol/L or plasma lactate levels
.2.0 mmol/L); arterial hypoxia (PO2 ,75 mm Hg, a PO2/FiO2 ratio
,250, or transcutaneous oxygen saturation ,96%) in patients without
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overt cardiopulmonary disease; acute renal failure (diuresis ,0.5 mL/
kgzh for at least 1 h despite acute volume loading or evidence of adequate
intravascular volume without preexisting renal disease); or sudden de-
terioration of the baseline mental status. The patients participated in a
randomized, double-blinded, dose-finding study of protein C concen-
trate (human; Immuno-Baxter, Vienna, Austria). Because protein C is
assumed not to influence the endocrine and metabolic assays and did not
influence mortality we did not account for it in further analysis. The
Medical Ethics Committee of the Erasmus University Rotterdam ap-
proved the study protocol. Informed consent was obtained from the
parents or legal representatives.
Clinical parameters
The pediatric risk of mortality (PRISM II) score was calculated based
on the most abnormal values regarding 14 physiological variables dur-
ing the first 6 h of admission. A higher score means a higher risk of
mortality (13–15). The interval between appearance of petechiae and
admission to the PICU, length of stay in the PICU, and duration of
inotropic support were recorded. To distinguish nonsurvivors from
survivors established parameters to monitor the severity of disease, such
as PRISM, lactate, and C-reactive protein (CRP) were analyzed (14, 15).
Collection of blood
Arterial blood samples were collected within 2 h after admission (T 5
0), after 24 h (T 5 24), and 48 h (T 5 48) for determination of thyroid
hormones, insulin, glucose, pre-albumin, CRP, nonesterified free fatty
acids (NEFAs), and lactate. Blood samples for cortisol and ACTH were
taken at T 5 0 and 12 h (T 5 12) after admission. An ACTH test was not
performed because all children had severe stress due to the life-threat-
ening disease on admission. A diurnal rhythm for cortisol and ACTH
was estimated by sampling blood on the second day of admission at
0800 h and subsequently at 1400 and 2000 h.
Hormonal assays
Cortisol/ACTH. The plasma concentrations of cortisol were measured by
competitive luminescence immunoassay. The detection limits were
0.03–1.38 mmol/L. The plasma concentrations of ACTH were measured
by immunoradiometric assay (ELSA-ACTH; CIS-Bio International, Gif-
suryvette, France), using two monoclonal antibodies. The within-run
coefficients of variation were 6.1% at 22 pg/mL, 2.9% at 59 pg/mL, and
2.1% at 778 pg/mL. The between-run coefficients of variation were 5.3%
at 40 pg/mL, 4.8% at 203 pg/mL and 1.3% at 1055 pg/mL. The reference
values for cortisol were: 0800 h, 0.2–0.6 mmol/L; 1400 h, 0.1–0.5 mmol/L;
and 2000 h, 0.05–0.3 mmol/L. The reference value for ACTH was 20–100
ng/L. From the values of cortisol and ACTH the cortisol/ACTH ratio
was calculated.
Thyroid hormones. Plasma T4, T3, and reverse T3 (rT3) were measured by
established RIA procedures, as described previously (16, 17). The ref-
erence values of the laboratory were: T4, 64–132 nmol/L; T3, 1.1–2.6
nmol/; and rT3, 0.15–0.43 nmol/L. From the values of T3 and rT3 the
T3/rT3 ratio was calculated. The plasma concentrations of free T4 (fT4)
were measured by a direct, labeled antibody, competitive immunoassay
technique (Amerlite MAB fT4 Assay; Ortho-Clinical Diagnostics, Strass-
bourg, France). The within-assay coefficients of variation were 7.6% at
5.43 pmol/L, 4.3% at 16.1 pmol/L, and 3.5% at 52.8 pmol/L. The be-
tween-assay coefficients of variation were 9.0% at 5.67 pmol/L, 5.6% at
17.4 pmol/L, and 4.2% at 49.2 pmol/L. The reference value for fT4 was
11–25 pmol/L.
The plasma concentrations of TSH were measured by an ultrasensi-
tive immunometric assay (Amerlite TSH-30; Ortho-Clinical Diagnos-
tics), using one monoclonal antibody. The within-assay coefficients of
variation were 8.0% at 0.087 mIU/L, 4.2% at 4.22 mIU/L, and 4.1% at
21.5 mIU/L. The between-assay coefficients of variation were 11.7% at
0.077 mIU/L, 6.6% at 4.25 mIU/L, and 5.1% at 21.4 mIU/L. The reference
value for TSH was less than 4.5 mE/L.
Insulin/glucose. Insulin was measured in serum with an immunoradio-
metric assay. The detection limit was 5–400 mU/L. Glucose measure-
ments were determined on the routine clinical chemistry analyzers (Di-
mension ES; Dupont Medical Products, Wilmington, DE) (reference
values: hypoglycemia, ,2.6 mmol/L; hyperglycemia, .11 mmol/L).
From the values of insulin and glucose the insulin to glucose ratio was
calculated.
Metabolic assays
Lactate was measured by enzymatic end point determination (Hitachi
911; Roche Molecular Biochemicals, Mannheim, Germany) (normal,
,2.0 mmol/L). CRP was determined by an immunonephelometric assay
(normal, ,5 mg/L) (18). Plasma NEFA concentrations were determined
by the enzymatic method (Nefac-kit; Wako, Instruchemie BV, Neuss,
Germany). The reference values for NEFAs were: children between 4
months and 10 yr, 0.3–1.1 mmol/L; children more than 10 yr, 0.2–0.8
mmol/L.
Urinary nitrogen excretion
Urine was collected daily for 24 h and analyzed for urinary nitrogen.
Total urinary nitrogen excretion was defined as 1.253 urinary urea
nitrogen, to adjust for the urinary nitrogen loss as ammonia, creatinine,
and uric and amino acids (19). No correction was made for nitrogen
losses through stools, skin, wounds, nasogastric suction, or blood
sampling.
Caloric intake
The patients were fed enteral and/or parenteral according to a stan-
dard feeding protocol. During the stay in the PICU glucose was ad-
ministered at a rate of ;4–6 mg/kgzmin. If enteral feeding could not be
started on the second day, parenteral feeding was started. The initial
dose of proteins was 1.0 g/kgzday (Aminoveno¨s N-paed 10%; Fresenius,
’s-Hertogenbosch, Holland) and of lipids (in case the body temperature
was ,38.5 C) was 1.0 g/kgzday (Intralipid 20%; Pharmacia & Upjohn,
Inc., Woerden, Holland). If clinically possible, enteral and/or parenteral
nutrition was adjusted on days 3 and 4 to normal needs for healthy
children. The total caloric intake was recorded and calculated daily. The
amount of caloric intake was corrected for extra protein calories such as
plasma and/or albumin infusions. To estimate the adequacy of caloric
intake, the amount of energy intake was compared with calculated
values for resting energy expenditure for healthy children according to
the formula of Schofield (20) for age, sex, and weight.
Statistics
Statistical analysis was performed with a statistical analysis software
program (SPSS 7.0 for Windows 95; SPSS, Inc., Chicago, IL). The results
are expressed as medians (interquartiles), unless specified otherwise.
The Mann-Whitney U test was used for comparison of clinical and
laboratory tests between survivors and nonsurvivors. For survivors, the
Wilcoxon signed rank test was used for comparison on different time
points of different laboratory tests. Spearman’s correlation coefficient (r)
was used to evaluate the relationship between different parameters.
Two-tailed P values of 0.05 or less were considered statistically
significant.
Results
Demographics
Twenty-six patients admitted to the PICU fulfilled the
inclusion criteria and were included in the study; there were
16 males and 10 females (Table 1). The median age was 23
months (range, 4–185). Cultures of blood revealed Neisseria
meningitidis in all 26 patients.
Clinical parameters
Eight children died after a median stay in the PICU for 10 h
(range, 2–40); eighteen children survived, and they stayed in
the PICU for a median of 86 h (range, 30–312). There was a
significant difference in age between nonsurvivors and sur-
vivors (10 vs. 29 months, P , 0.05). The interval between
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appearance of petechiae and admission to the PICU was 5.8 h
(range, 2.5–18.). There was a significant difference between
nonsurvivors and survivors for the interval between appear-
ance of petechiae and admission to the PICU (3.5 vs. 7.0 h, P ,
0.05). Concomitant therapy during the study period included
antibiotics, administration of plasma, and inotropics for all
patients [10 patients received dopamine, 22 received nor-
adrenaline, and 25 received dobutamine (24 patients re-
ceived a combination of inotropics)]. Nonsurvivors received
significantly higher doses of inotropics (dobutamine and
noradrenaline, P , 0.01). The 18 survivors received inotropic
therapy for a median of 49 h (range, 9–170). Administration
of corticosteroids is not a routine procedure in The Nether-
lands. For that reason, none of the children received corti-
costeroid therapy on admission. Seventeen patients required
mechanical ventilatory support and sedation with benzodi-
azepines. The parameters to monitor severity of disease were
significantly different between nonsurvivors and survivors
[PRISM score (31 vs. 17, P , 0.01); arterial lactate levels (7.3
vs. 3.2 mmol/L, P , 0.01; Fig. 1); and CRP levels (34 vs. 78
mg/L, P , 0.01)] (Table 2). In survivors, compared with
levels on admission, lactate levels decreased significantly
after 24 and normalized after 48 h, and CRP levels were
significantly increased after 24 and 48 h.
Cortisol/ACTH
On admission, nonsurvivors had significantly lower se-
rum cortisol levels than survivors (0.62 vs. 0.89 mmol/L, P ,
0.05), whereas the ACTH levels were extremely high in those
who did not survive (1234 vs. 231 ng/L, P , 0.01) (Table 2
and Fig. 2). The cortisol/ACTH ratio was significantly dif-
ferent between nonsurvivors and survivors (P , 0.01). ACTH
and the cortisol/ACTH ratio correlated well with parameters
to monitor the severity of disease (PRISM, lactate, and CRP)
(Table 3). In those who survived 12 h after admission levels
of cortisol (0.73 mmol/L) and ACTH (31 ng/L) decreased
significantly in comparison with levels on admission; on the
second day after admission there was a further significant
decrease of levels of cortisol (0.54 mmol/L) and ACTH (18
ng/L) in comparison with levels on admission and the levels
of 12 h after admission (Table 2). In 14 survivors, on day 2,
a cortisol/ACTH profile was performed; in none of them
could a circadian rhythm be detected in the three samples
taken at 0800, 1400, and 2000 h.
TABLE 1. Endocrine and metabolic parameters on admission
Age
(months) Sex
Duration of petechiae
before admission (h)
PRISM
score Survival
4 M 7 12 Yes
5 M 3.5 30 No
5.5 M 3 34 No
7 F 4 32 No
9 F 3.5 19 No
10 F 9 16 Yes
10 M 7 32 No
12 F 9 18 Yes
15 F 4 18 Yes
18 M 5.5 27 Yes
19 M 1 15 Yes
21 M 15 18 Yes
21 M 8 29 No
24 M 0.5 37 No
25 M 15 21 Yes
27 F 10 14 Yes
30 M 3 24 Yes
32 F 6 10 Yes
52 F 9 20 Yes
77 M 7 15 Yes
81 F 11 7 Yes
113 M 3.5 29 No
128 M 4 9 Yes
136 M 4 24 Yes
141 M 10 24 Yes
185 F 6 14 Yes
M, Male; F, female; PRISM score, pediatric risk of mortality score.
TABLE 2. Endocrine and metabolic differences between survivors and nonsurvivors on admission and time course of survivors
Nonsurvivors Survivors Normal
referenceT 5 0 T 5 0 T 5 24a T 5 48
PRISM 31 (29–34) 17 (14–17)b,c
Cortisol, mmol/L 0.62 (0.49–0.79) 0.89 (0.77–1.15)b,c 0.54 (0.38–0.62)d,c 0.2–0.6
ACTH, ng/L 1234 (740–2915) 231 (48–665)b,c 18 (12–31)d,c 20–100
Cortisol/ACTH 0.5823 (0.1723–1.0023) 6.123 (1.823–21.723)b,c 2923 (1723–3423)d,c
TSH, mE/L 0.97 (0.52–1.56) 0.29 (0.15–0.54)b,c 0.55 (0.17–1.80) 1.73 (0.36–2.41)c,e ,4.5
T4, nmol/L 38 (25–46) 44 (39–56) 49 (38–64) 45 (34–71) 64–132
T3, nmol/L 0.53 (0.43–0.76) 0.38 (0.26–0.42)
b,f 0.58 (0.27–0.85)d,c 0.63 (0.29–0.97)e,f 1.1–2.6
rT3, nmol/L 0.75 (0.55–0.97) 1.44 (0.99–1.85)
b,c 1.52 (1.29–2.21) 0.98 (0.75–1.35)e,f,g,c 0.15–0.43
T3/rT3 0.76 (0.64–0.85) 0.43 (0.17–0.35)
b,c 0.43 (0.13–0.62) 0.87 (0.21–1.14)e,f,g,c
fT4, pmol/L 14 (13–21) 16 (15–19) 13 (12–19) 12 (9–19)
c,e 11–25
Insulin, mU/L 5 (5–7) 13 (5–21)b,c 16 (10–29) 19 (12–29)e,f
Glucose, mmol/L 3.9 (2.5–6.5) 6.3 (5.2–7.8)b,f 6.0 (5.7–8.0) 6.5 (5.5–7.2) 2.6–11
Insulin/glucose 1.8 (0.9–2.0) 1.8 (1.1–2.6) 2.7 (1.7–4.0) 3.1 (2.1–3.5)e,f ,50
CRP, mg/L 34 (24–37) 78 (58–100)b,c 201 (172–244)d,c 165 (133–219)c,e ,5
Lactate, mmol/L 7.3 (5.9–10.4) 3.2 (2.2–5.1)b,c 2.0 (1.5–2.8)d,f 1.5 (1.2–2.0)c,e ,2.0
NEFA, mmol/L 0.32 (0.25–0.50) 0.95 (0.7–1.4)b,c 0.73 (0.46–0.84)d,f 0.41 (0.28–0.77)c,e 0.3–1.1
a For cortisol and ACTH T 5 24 is 0800 h day 2.
b Significant difference between nonsurvivors and survivors.
c All values are expressed as median and interquartiles, P , 0.01.
d Significant difference between T 5 24 and T 5 0.
e Significant difference between T 5 48 and T 5 0.
f All values are expressed as median and interquartiles, P , 0.05.
g Significant difference between T 5 48 and T 5 24.
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Thyroid hormones
On admission, data of nonsurvivors and survivors showed
significant differences in levels of rT3 (0.75 vs. 1.44 nmol/L,
P , 0.01), the T3/rT3 ratio (0.76 vs. 0.43, P , 0.01), TSH (0.97
vs. 0.29 nmol/L, P , 0.01), and T3 (0.53 vs. 0.38 nmol/L, P ,
0.05), whereas the levels of T4 and fT4 were not significantly
different between the two groups (Table 2 and Fig. 3). In
comparison with normal reference values, the levels of T4
and T3 were decreased in both nonsurvivors and survivors,
and those of rT3 were increased. The median fT4 and TSH
levels were within the normal reference range. On admission,
there were, except for fT4, significant correlations between
levels of TSH, T3, rT3, and the T3/rT3 ratio with the param-
eters to monitor the severity of disease (Table 3). After 48 h
survivors showed significantly increased levels of TSH, T3,
and the T3/rT3 ratio and significantly decreased levels of rT3
and fT4 in comparison with levels on admission, whereas the
level of T4 did not change significantly. For survivors 48 h
after admission median levels of T3, T4, and rT3 remained
below normal reference values, whereas median fT4 and TSH
levels remained within the normal reference values (Fig. 2).
Insulin/glucose
On admission, nonsurvivors showed significantly differ-
ent levels of insulin (5 vs. 13 mU/L, P , 0.05) and glucose (3.9
vs. 6.3 mmol/L, P , 0.05) compared with survivors (Table 2
and Fig. 4). The insulin to glucose ratio did not show sta-
tistical significance between survivors and nonsurvivors (Ta-
ble 2). On admission, two of the children had a hypoglycemia
FIG. 1. Levels of lactate (A) and NEFA (B) on admission for nonsur-
vivors (0 nsurv) and survivors (0) and the time course of these levels
for survivors after 24 and 48 h. Reference values below or between
dotted lines.
FIG. 2. Levels of cortisol (A), ACTH (B), and the cortisol/ACTH ratio
(C) on admission for nonsurvivors (0 nsurv) and for survivors (0) and
the time course for survivors after 12 h and on day 2 at 0800 h, 1400
h, and 2000 h. Reference values between dotted lines.
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(2.4 and 1.6 mmol/L) and two children had a hyperglycemia
(11.6 and 14.3 mmol/L). After 48 h survivors showed sig-
nificantly increased levels for insulin and the insulin to glu-
cose ratio in comparison with levels on admission, whereas
the levels of glucose showed no changes (Fig. 4). There were
no significant correlations between insulin, glucose and the
insulin to glucose ratio vs. the levels of cortisol and the
parameters to monitor the severity of disease (Table 3).
NEFAs
On admission, nonsurvivors had significantly lower
NEFA levels than survivors (0.32 vs. 0.95 mmol/L, P , 0.01)
(Table 2 and Fig. 1). Median NEFA levels for both nonsur-
vivors and survivors remained within normal reference val-
ues on admission. NEFA levels decreased significantly after
48 h in comparison with the levels of admission and after
24 h. Levels of NEFA correlated negatively with lactate and
PRISM score (P , 0.01) (Table 3).
Nitrogen excretion
Nitrogen excretion was assessed in 16 survivors. The me-
dian nitrogen excretion was not significantly different be-
tween the first 24 h and the second 24 h after admission 271
mg/kgzday (range, 64–940) vs. 251 mg/kgzday (range,
152–737).
Caloric intake
For survivors, the median difference between actual en-
ergy intake and calculated resting energy expenditure was
245% (range, 283% to 24%) during the first 24 h after ad-
mission and 242% (range, 283% to 27%) during the second
24 h after admission.
Time course in nonsurvivors
Six of the eight nonsurvivors died within 14 h because
shock persisted in all; in two of these six children it was
combined with pulmonary edema, in one child with con-
vulsions, in one child with pulmonary hypertension, and in
one child with cerebral death. Two children died after 24 h
(25 and 40 h). For these children, the interval between ap-
pearance of petechiae and admission to the PICU was sig-
nificantly longer (7 and 8 h) compared with the other six
children [median, 3.5 h (range, 0.5–4. h; P , 0.05)]. These two
children also showed higher cortisol levels on admission
(0.73 and 1.05 mmol/L; Fig. 2, E) than the other six children.
After 24 h both children showed decreased levels of ACTH,
but these levels still remained above normal reference values
(163 and 805 ng/L). In one of these two children a cortisol
measurement was done after 24 h, showing only a slight
improvement of the level of cortisol (from 0.73 to 0.80
mmol/L) in view of the ultimate state of stress. Furthermore,
both children showed after 24 h an increase in rT3 levels
(from 0.95 to 1.65 nmol/L) and CRP (from 34 to 111 mg/L).
The level of lactate, however, increased in both children. In
the child who lived for 40 h shock persisted, recurrent con-
vulsions developed, and severe bradycardias occurred a few
hours before death. In the child who lived for 25 h shock
persisted, and a combination with severe pulmonary hyper-
tension lead to death.
Discussion
Our study shows that children who do not survive me-
ningococcal sepsis have an impaired adrenal response, al-
tered thyroid hormones, and decreased levels of NEFAs,
associated with a higher severity of disease score on admis-
sion. The observed endocrine and metabolic changes are of
such clinical importance to reconsider therapeutic strategies.
One of the most striking alterations in our study concerned
a significant difference in cortisol/ACTH response between
nonsurvivors and survivors on admission. Nonsurvivors
showed an inadequate cortisol response in combination with
very high ACTH levels, whereas survivors showed a normal
stress response with significantly higher cortisol levels in
combination with moderately increased ACTH levels. ACTH
and the cortisol/ACTH ratio were strongly correlated with
survival and parameters to monitor the severity of disease.
Low cortisol levels in nonsurvivors and high cortisol levels
in survivors have been reported in the past in children with
meningococcal sepsis (21, 22). More recently, only one other
study in children with meningococcal sepsis reported the
levels of ACTH in relation with the levels of cortisol. Sig-
nificantly higher ACTH levels were found in those who died
(23). The decreased production of cortisol in relation with
high levels of ACTH might be caused by various mecha-
nisms. First, the low production of cortisol might be the result
of bilateral adrenal hemorrhages [described previously as the
Waterhouse-Friderichsen syndrome (21, 22)], due to severe
coagulation disorders found in meningococcal sepsis (15).
Second, alternatively, an inadequate perfusion of the adrenal
cortex due to hypotension might have lead to impaired ad-
renal function with diminished cortisol production. Our
study seems to support this mechanism because we found a
strong negative correlation between levels of cortisol and
lactate. Third, in the presence of higher levels of endotoxin
and tumor necrosis factor a (as seen in nonsurvivors), there
might be a decreased adrenal ACTH receptor binding and a
suppressed synthesis of cortisol (24, 25). Salem et al. (26)
reported a family of peptides (called corticostatins) that
TABLE 3. Nonlinear significant correlation-coefficients
(Spearman) between endocrine parameters, NEFA, and
parameters to monitor severity of disease (lactate, CRP, and
PRISM score) on admission
Lactate CRP PRISM
Cortisol 20.40a 0.10 20.37
ACTH 0.57a 20.64b 0.68b
Cort/ACTH 20.63b 0.54a 20.64b
TSH 0.53b 20.43a 0.42a
T4 0.07 0.06 20.34
T3 0.45
a 20.49a 0.29
rT3 20.34 0.48
a 20.41a
T3/rT3 0.42
a 20.51a 0.35
fT4 0.40 20.17 20.41
Insulin 20.09 0.18 20.35
Glucose 20.23 0.15 20.36
Insulin/glucose 0.19 0.04 20.06
NEFA 20.47a 0.32 20.48a
a P , 0.05.
b P , 0.01.
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might impair the sensitivity of the adrenals to ACTH during
sepsis. It remains a question whether treatment with sup-
plemental steroids, which is not a routine treatment in The
Netherlands, will be beneficial (27). In our study, there was
a very rapid and aggressive course of the disease in four of
the five nonsurvivors who died within 12 h after admission.
In nonsurvivors the interval between appearance of pete-
chiae and admission to the PICU was significantly shorter
compared with survivors, indicating the importance of the
time course of disease. We believe that if corticosteroid treat-
ment is started after referral and admission on the intensive
care unit therapy might only benefit a very small group of
children. In that case, the time delay before initial cortico-
steroid treatment the infection process might have gone be-
yond any currently available therapeutic approach. Based on
our data, however, we feel that a large randomized, double-
blind, controlled study has to be designed to treat children
with steroids as soon as possible after the first signs of dis-
ease. The results of this study might give an answer on the
role of administration of steroids with in respect the time
course of the disease.
During critical illness, cortisol has an important role on
the metabolism of fatty acids, glucose, and protein (28).
There is evidence to suggest that NEFAs may be the pre-
ferred fuel for oxidation in critical illness (29). In our study,
we found on admission a positive correlation between
levels of cortisol and NEFAs. Nonsurvivors had significant
lower levels of NEFAs than survivors, indicating a lack
of an adequate metabolic stress response in those who
died. Nonsurvivors also showed significant lower levels
of glucose, but there was no correlation with the levels of
cortisol, indicating other mechanisms causing hypoglyce-
mia (30).
In this study, we examined the ACTH/cortisol axis as an
FIG. 3. Levels of T3 (A), rT3 (B), TSH (D), and ratio T3/rT3 (C) on admission for nonsurvivors (0 nsurv) and for survivors (0) and the time course
of these levels for survivors after 24 and 48 h. Reference values below or between dotted lines.
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important modulator of cardiovascular and metabolic ho-
meostasis during critical illness. We did not examine the
serum concentrations of the catecholamines and glucagon
that might have influenced the anabolic effects of insulin and
GH. Preliminary data of a comparable group of children with
meningococcal sepsis showed that nonsurvivors had signif-
icantly increased levels of GH and low levels of insulin-like
growth factor I compared with survivors (manuscript in
preparation). Research is in progress to assess the etiology
and consequences of the alterations of the GH/insulin-like
growth factor I axis.
Alterations in the thyroid axis in critically ill children are
called “the euthyroid sick syndrome” (8–12). In our study,
both survivors and nonsurvivors showed the features of “the
euthyroid sick syndrome,” decreased levels of T3 and T4,
increased levels of rT3, normal levels of fT4, and no com-
pensatory increased levels for TSH. Nonsurvivors, however,
showed significantly higher T3 levels and lower rT3 levels
compared with survivors. Low levels of T3 and increased
levels of rT3 are explained by an adaptive mechanism aimed
at preventing protein catabolism and lowering energy re-
quirements in severely ill patients. It might, thus, be postu-
lated that nonsurvivors are not able to adapt in the same way
as survivors (31–34). The euthyroid sick syndrome may be
mediated by cytokines and can be induced or aggravated by
dopamine and glucocorticoids, whereas somatostatin may
play a suppressive role (9, 28, 35–37.). In our study, 10 of the
survivors received dopamine. Our study was not designed
to study the immediate relation of thyroid function after
dopamine withdrawal as done previously in children after
cardiac surgery (28).
To get a better insight in the resolution of the hormonal
and metabolic changes in children who survived, we eval-
uated the time course. Cortisol and ACTH levels in those
who survived were on day 2 already significantly lower
compared with the levels on admission and after 12 h. The
cortisol and ACTH levels were within normal reference val-
ues, however, the circadian rhythm of cortisol was not seen.
These findings suggest a persisting hyperactivity of the ad-
renal gland despite normalization of cortisol and ACTH lev-
els. Furthermore, 2 days after admission levels of total T4
remained unaltered, whereas levels of fT4 and TSH increased
but remained within normal reference values. Levels of rT3
decreased and levels of T3 and the T3/rT3 ratio increased, but
all these levels still remained below normal reference values.
These data indicate a slightly restoration but not a normal-
ization of the thyroid function at day 2. Levels of NEFAs had
decreased significantly at 2 days after admission, indicating
that lipolysis had diminished. Levels of insulin and glucose
showed a variable pattern within the normal range during
the first 2 days after admission, which is in contrast to studies
in critically ill adults where hyperglycemia and glucose in-
tolerance with elevated insulin levels are hallmarks of
stressed metabolism (38). Whether children with septic shock
have a different insulin/glucose response compared with
adults is not known. Although several hormonal axes and
levels of NEFAs and lactate indicated the restoration of anab-
olism at the second day after admission, the urea nitrogen
excretion did not change significantly and remained high.
This is in accordance with studies in critically ill adult pa-
tients in which protein breakdown remained increased after
the return to baseline values of the stress hormones and
cytokines (39). In some studies of critically ill adult patients
and critically ill children an improvement in protein syn-
thetic rate or an improvement of nitrogen retention could be
achieved by provision of exogenous nutrition (40–42). In our
study, the provision of calories was far below the estimated
need for calories during the first 2 days after admission
(respectively, 45% and 42% too low). The low caloric supply
might, therefore, be responsible for the high and unaltered
excretion of nitrogen during these days in our patients.
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